Literature DB >> 24099361

Effects of a novel CB1 agonist on visual attention in male rats: role of strategy and expectancy in task accuracy.

Rikki L A Miller1, Ganesh A Thakur, William N Stewart, Joshua P Bow, Shama Bajaj, Alexandros Makriyannis, Peter J McLaughlin.   

Abstract

The effects of cannabinoid CB1 agonists (including Δ9-tetrahydrocannabinol, the main psychoactive component of marijuana) on attention are uncertain, with reports of impairments, no effects, and occasionally performance enhancements. To better understand these effects, we sought to uncover a role of changing online (within-session) strategy as a possible mediator of the effects of the novel, potent CB1 agonist AM 4054, on a model of sustained attention in male Sprague-Dawley rats. In this operant, two-choice reaction time (RT) task, AM 4054 decreased accuracy in an asymmetric manner; that is, performance was spared on one lever but impaired on the other. Furthermore, this pattern was enhanced by the outcome of the previous trial such that AM 4054 strengthened a win-stay strategy on the "preferred" lever and a lose-shift strategy on the "nonpreferred" lever. This pattern is often found in tests of expectancy; therefore, in a second experiment AM 4054 enhanced expectancy that we engendered by altering the probability of the two stimulus cues. Accuracy was impaired in reporting the less frequent cue, but only after two or more presentations of the more frequent cue. Taking the results of the experiments together, AM 4054 engendered expectancy by increasing the role of previous trial location and outcome on performance of future trials, diminishing stimulus control (and therefore, accuracy). This novel effect of CB1 receptor agonism may contribute to the deleterious effects of cannabinoids on attention. PsycINFO Database Record (c) 2013 APA, all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24099361      PMCID: PMC4006576          DOI: 10.1037/a0033668

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  38 in total

1.  Cannabis use, cognitive performance and mood in a sample of workers.

Authors:  E J K Wadsworth; S C Moss; S A Simpson; A P Smith
Journal:  J Psychopharmacol       Date:  2005-10-04       Impact factor: 4.153

2.  Behavioral effects of the novel cannabinoid full agonist AM 411.

Authors:  Peter J McLaughlin; Dai Lu; Keisha M Winston; Ganesh Thakur; Lynn A Swezey; Alexandros Makriyannis; John D Salamone
Journal:  Pharmacol Biochem Behav       Date:  2005-04-21       Impact factor: 3.533

3.  Alterations in behavioral flexibility by cannabinoid CB1 receptor agonists and antagonists.

Authors:  Matthew N Hill; Larissa M Froese; Anna C Morrish; Jane C Sun; Stan B Floresco
Journal:  Psychopharmacology (Berl)       Date:  2006-06-03       Impact factor: 4.530

Review 4.  Some effects of CB1 antagonists with inverse agonist and neutral biochemical properties.

Authors:  Jack Bergman; Marcus S Delatte; Carol A Paronis; Kiran Vemuri; Ganesh A Thakur; Alex Makriyannis
Journal:  Physiol Behav       Date:  2007-11-12

5.  Neuroimaging of marijuana smokers during inhibitory processing: a pilot investigation.

Authors:  Staci A Gruber; Deborah A Yurgelun-Todd
Journal:  Brain Res Cogn Brain Res       Date:  2005-04

6.  The novel cannabinoid agonist AM 411 produces a biphasic effect on accuracy in a visual target detection task in rats.

Authors:  P J McLaughlin; C M Brown; K M Winston; G Thakur; D Lu; A Makriyannis; J D Salamone
Journal:  Behav Pharmacol       Date:  2005-09       Impact factor: 2.293

7.  Spatial signal detection in rats is differentially disrupted by delta-9-tetrahydrocannabinol, scopolamine, and MK-801.

Authors:  G Presburger; J K Robinson
Journal:  Behav Brain Res       Date:  1999-02-15       Impact factor: 3.332

8.  Marijuana use is associated with a reorganized visual-attention network and cerebellar hypoactivation.

Authors:  L Chang; R Yakupov; C Cloak; T Ernst
Journal:  Brain       Date:  2006-04-03       Impact factor: 13.501

9.  Acute effects of smoked marijuana on decision making, as assessed by a modified gambling task, in experienced marijuana users.

Authors:  Nehal P Vadhan; Carl L Hart; Wilfred G van Gorp; Erik W Gunderson; Margaret Haney; Richard W Foltin
Journal:  J Clin Exp Neuropsychol       Date:  2007-05       Impact factor: 2.475

10.  Behavioral effects of the novel potent cannabinoid CB1 agonist AM 4054.

Authors:  Peter J McLaughlin; Ganesh A Thakur; V Kiran Vemuri; Evan D McClure; Cara M Brown; Keisha M Winston; Jodianne T Wood; Alexandros Makriyannis; John D Salamone
Journal:  Pharmacol Biochem Behav       Date:  2013-04-19       Impact factor: 3.533

View more
  4 in total

1.  The effects of synthetic cannabinoids on executive function.

Authors:  K Cohen; M Kapitány-Fövény; Y Mama; M Arieli; P Rosca; Z Demetrovics; A Weinstein
Journal:  Psychopharmacology (Berl)       Date:  2017-02-03       Impact factor: 4.530

Review 2.  Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications.

Authors:  Marisol S Castaneto; David A Gorelick; Nathalie A Desrosiers; Rebecca L Hartman; Sandrine Pirard; Marilyn A Huestis
Journal:  Drug Alcohol Depend       Date:  2014-08-18       Impact factor: 4.492

Review 3.  The Effects of Cannabinoids on Executive Functions: Evidence from Cannabis and Synthetic Cannabinoids-A Systematic Review.

Authors:  Koby Cohen; Aviv Weinstein
Journal:  Brain Sci       Date:  2018-02-27

4.  An Ultra-Low Dose of ∆9-Tetrahydrocannabinol Alleviates Alzheimer's Disease-Related Cognitive Impairments and Modulates TrkB Receptor Expression in a 5XFAD Mouse Model.

Authors:  Keren Nitzan; Leah Ellenbogen; Ziv Bentulila; Dekel David; Motty Franko; Emanuela P Break; Michal Zoharetz; Alon Shamir; Yosef Sarne; Ravid Doron
Journal:  Int J Mol Sci       Date:  2022-08-21       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.